 | | | | More than a third of high school students surveyed in the United States experienced stress, anxiety or depression, and nearly a fifth said they seriously considered suicide during the COVID-19 pandemic, U.S. researchers reported on Thursday. | | | | | | Germany plans to end mandatory quarantine for most people who catch COVID-19, the health ministry proposed on Thursday, as numbers isolating with the infection top four million. | | | | | | France is facing its worst bird flu crisis in history as a rare rebound in outbreaks of the highly contagious virus reached the country's largest poultry producing regions with cullings topping more than 12 million birds. | | | | | | Chinese President Xi Jinping has urged the country to take more effective COVID-19 measures and minimise the impact of the epidemic on economic development, state television said on Thursday, as the country battles a new wave of infections. | | | | | | Pakistan has disbanded the National Command and Operations Center (NCOC), which was overseeing the COVID-19 response in the country, as the infection's numbers were at the lowest since the start of the outbreak early in 2020,the prime minister said on Thursday. | | | | | | Walgreens Boots Alliance Inc kept its 2022 earnings forecast unchanged even as it beat estimates for second-quarter results, sending the drugstore chain's shares down 7% on fears of slower-than-expected growth for the rest of the year. | | | | | | As governments prepare to live with COVID-19, some are questioning how much to rely on drugmakers to adapt vaccines to ward off future virus variants amid signs of tension between companies and regulators over the best approach, according to several sources familiar with the matter. | | | | | | Hong Kong reported 6,646 new coronavirus infections on Thursday, down from 6,981 the previous day, and 119 deaths as daily infections continue to decline in the global financial hub, which is gradually easing restrictions. | | | | | | German drugmaker Bayer said it would invest around 2 billion euros ($2.23 billion) at pharmaceutical manufacturing sites over the next three years, mainly to bolster production of biotechnology drugs as well as cell and gene therapies. | | | | | | Fresenius's generic drugs unit Kabi has agreed to buy a majority stake in the mAbxience division of Spain's Insud Pharma to expand its business making cheaper versions of biotechnology drugs that have lost patent protection. | | | | | |
